This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woo, J.-H. Articles by Kwon, T. K. Search for Related Content PubMed PubMed Citation Articles by Woo, J.-H. Articles by Kwon, T. K.

Dykellic Acid Inhibits Phorbol Myristate Acetate-induced Matrix Metalloproteinase-9 Expression by Inhibiting Nuclear Factor B Transcriptional Activity¹

Department of Immunology, School of Medicine, Keimyung University, Taegu 700-712, Korea [J-H. W., J-W. P., S-H. L., Y-H. K., I. K. L., T. K. K.]; Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 [E. G.]; and Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon 305-333, Korea [S-H. L., H-J. L., Y-H. K.]

Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with expression of endopeptidases known as matrix metalloproteinases (MMPs). Expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate. We found that dykellic acid, a fungal metabolite, significantly inhibits the phorbol myristate acetate-induced increase in MMP-9 expression and activity. These effects of dykellic acid are time- and dose-dependent, and correlate with decreased MMP-9 promoter activity and mRNA expression. Whereas this compound does not affect DNA binding activity of nuclear factor B (NFB), dykellic acid does inhibit transactivation of NFB. These data demonstrate a role for NFB in the regulation of MMP-9 expression and the ability of dykellic acid to suppress this action of NFB.

This article has been cited by other articles:

				M. Tanaka, K. Sasaki, R. Kamata, and R. Sakai The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells J. Cell Sci., July 1, 2007; 120(13): 2179 - 2189. [Abstract] [Full Text] [PDF]

				H.-J. Cho, J. H. Kang, J.-Y. Kwak, T.-S. Lee, I.-S. Lee, N. G. Park, H. Nakajima, J. Magae, and Y.-C. Chang Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms Carcinogenesis, May 1, 2007; 28(5): 1104 - 1110. [Abstract] [Full Text] [PDF]

				S. Han, J. D. Ritzenthaler, S. V. Sitaraman, and J. Roman Fibronectin Increases Matrix Metalloproteinase 9 Expression through Activation of c-Fos via Extracellular-regulated Kinase and Phosphatidylinositol 3-Kinase Pathways in Human Lung Carcinoma Cells J. Biol. Chem., October 6, 2006; 281(40): 29614 - 29624. [Abstract] [Full Text] [PDF]

				S. Hong, K.-K. Park, J. Magae, K. Ando, T.-S. Lee, T. K. Kwon, J.-Y. Kwak, C.-H. Kim, and Y.-C. Chang Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway: INHIBITORY EFFECTS OF ASCOCHLORIN ON THE INVASION OF RENAL CARCINOMA CELLS J. Biol. Chem., July 1, 2005; 280(26): 25202 - 25209. [Abstract] [Full Text] [PDF]